Comment on "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study".
暂无分享，去创建一个
M. Brown | Wenbo Yu | Angel F. Lopez | T. Gargett | T. Hughes | Amy Hughes | A. Yong | Jade Clarson | J. Clarson
[1] D. Felsher,et al. KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study. , 2016, Leukemia research.
[2] M. Graf,et al. Expression Profile of the Progenitor Cell Markers CD34, CD38 and CD90 in Acute Myeloid Leukemia and Their Prognostic Significance , 2010 .
[3] Laurie E Ailles,et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.